| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0003 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |